SAT0113 LIMITING FACTORS OF REACHING ACR/EULAR BOOLEAN REMISSION IN EARLY RA PATIENTS TREATED ACCORDING TO CURRENT GUIDELINES
Sign Up to like & getrecommendations! Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2019-eular.3212
Abstract: Background Abrogation of inflammation is important to prevent irreversible joint damage and maximize health-related quality of life in early RA patients. The ACR/EULAR Boolean remission criteria have the most stringent remission definition.(1) It has been… read more here.
Keywords: boolean remission; pfizer; remission; acr eular ... See more keywords
Inflammation and biologic therapy in patients with rheumatoid arthritis achieving versus not achieving ACR/EULAR Boolean remission in a treat-to-target study
Sign Up to like & getrecommendations! Published in 2022 at "RMD Open"
DOI: 10.1136/rmdopen-2021-002013
Abstract: Objective To investigate limiting factors of American College of Rheumatology (ACR)/EULAR Boolean remission in rheumatoid arthritis (RA), and compare patients who fulfil the criteria to patients who only partly fulfil the criteria, with respect to… read more here.
Keywords: inflammation; eular boolean; boolean remission; acr eular ... See more keywords